ARMATA PHARMACEUTICALS, INC. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 96.00% for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2015-05-15
- ARMATA PHARMACEUTICALS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 96.00%.
- ARMATA PHARMACEUTICALS, INC. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2013 was 177.00%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|
| 2015-03-31 | 96.00% 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 91.00% 10-Q · filed 2015-05-15 | |
| 2013-12-31 | 177.00% 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |